BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 6,100.00
+430.00 (7.58%)
At close: Sep 8, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 618.30 billion as of September 8, 2025. Its market cap has increased by 36.15% in one year.
Market Cap
618.30B
Enterprise Value
269.25B
Revenue
112.04B
Ranking
n/a
PE Ratio
5.16
Stock Price
6,100.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 618.30B, a decrease of -43.01%. That is a compound annual growth rate of -18.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 574.72B | 19.56% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1,084.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |